Literature DB >> 16793961

Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein.

Marco Janner1, Amit V Pandey, Primus E Mullis, Christa E Flück.   

Abstract

OBJECTIVE: A severely virilized 46, XX newborn girl was referred to our center for evaluation and treatment of congenital adrenal hyperplasia (CAH) because of highly elevated 17alpha-hydroxyprogesterone levels at newborn screening; biochemical tests confirmed the diagnosis of salt-wasting CAH. Genetic analysis revealed that the girl was compound heterozygote for a previously reported Q318X mutation in exon 8 and a novel insertion of an adenine between nucleotides 962 and 963 in exon 4 of the CYP21A2 gene. This 962_963insA mutation created a frameshift leading to a stop codon at amino acid 161 of the P450c21 protein. AIM AND METHODS: To better understand structure-function relationships of mutant P450c21 proteins, we performed multiple sequence alignments of P450c21 with three mammalian P450s (P450 2C8, 2C9 and 2B4) with known structures as well as with human P450c17. Comparative molecular modeling of human P450c21 was then performed by MODELLER using the X-ray crystal structure of rabbit P450 2B4 as a template.
RESULTS: The new three dimensional model of human P450c21 and the sequence alignment were found to be helpful in predicting the role of various amino acids in P450c21, especially those involved in heme binding and interaction with P450 oxidoreductase, the obligate electron donor.
CONCLUSION: Our model will help in analyzing the genotype-phenotype relationship of P450c21 mutations which have not been tested for their functional activity in an in vitro assay.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16793961     DOI: 10.1530/eje.1.02172

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  7 in total

1.  A unique haplotype of RCCX copy number variation: from the clinics of congenital adrenal hyperplasia to evolutionary genetics.

Authors:  Márton Doleschall; Andrea Luczay; Klára Koncz; Kinga Hadzsiev; Éva Erhardt; Ágnes Szilágyi; Zoltán Doleschall; Krisztina Németh; Dóra Török; Zoltán Prohászka; Balázs Gereben; György Fekete; Edit Gláz; Péter Igaz; Márta Korbonits; Miklós Tóth; Károly Rácz; Attila Patócs
Journal:  Eur J Hum Genet       Date:  2017-04-12       Impact factor: 4.246

2.  Detection of a novel severe mutation affecting the CYP21A2 gene in a Chilean male with salt wasting congenital adrenal hyperplasia.

Authors:  Eugenio Arteaga; Felipe Valenzuela; Carlos F Lagos; Marcela Lagos; Alejandra Martinez; Rene Baudrand; Cristian Carvajal; Carlos E Fardella
Journal:  Endocrine       Date:  2019-09-30       Impact factor: 3.633

3.  A Case of Salt-Wasting Congenital Adrenal Hyperplasia with Triple Homozygous Mutation: Review of Literature.

Authors:  Maria Laura Iezzi; Gaia Varriale; Luca Zagaroli; Stefania Lasorella; Marco Greco; Giulia Iapadre; Alberto Verrotti
Journal:  J Pediatr Genet       Date:  2020-03-09

Review 4.  Pharmacogenomics of human P450 oxidoreductase.

Authors:  Amit V Pandey; Patrick Sproll
Journal:  Front Pharmacol       Date:  2014-05-09       Impact factor: 5.810

5.  Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations.

Authors:  Vassos Neocleous; Christos Shammas; Alexia Ap Phedonos; Leonidas A Phylactou; Nicos Skordis
Journal:  Indian J Endocrinol Metab       Date:  2014-11

6.  Characterization of Mutations Causing CYP21A2 Deficiency in Brazilian and Portuguese Populations.

Authors:  Mayara J Prado; Shripriya Singh; Rodrigo Ligabue-Braun; Bruna V Meneghetti; Thaiane Rispoli; Cristiane Kopacek; Karina Monteiro; Arnaldo Zaha; Maria L R Rossetti; Amit V Pandey
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

7.  A novel 9-bp insertion detected in steroid 21-hydroxylase gene (CYP21A2): prediction of its structural and functional implications by computational methods.

Authors:  Sudhisha Dubey; Susan Idicula-Thomas; Mohammad Anwaruddin; Chinnaraj Saravanan; R Raveendra Varma; Anurupa Maitra
Journal:  J Biomed Sci       Date:  2009-01-08       Impact factor: 8.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.